N/A
Completed N=567
A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use
Source: ClinicalTrials.gov NCT00784641 ↗Enrolled (actual)
567
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcomePrimary: Percentage of Participants With Favorable Responses for the Initial Lens Performance Survey — 340; 293; 326; 363 eyes
Summary
Evaluation of the clinical performance of a novel Bausch & Lomb daily disposable contact lens when compared to the currently marketed Bausch & Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft contact lens wearers on a daily disposable basis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Favorable Responses for the Initial Lens Performance Survey |
340; 293; 326; 363; 333; 339 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects with VA correctable to 0.3 logMAR (driving vision) or better in each eye.
- Subjects must have clear central corneas and be free of any anterior segment disorders.
- Subjects must be myopic and require lens correction in both eyes.
Exclusion Criteria
- Subjects with any systemic disease affecting ocular health.
- Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
- Subjects wearing monovision, multifocal or toric contact lenses.
- Subjects with grade 2 or greater slit lamp findings.
Data sourced from ClinicalTrials.gov (NCT00784641). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.